Mucosal veterinary vaccines: Comparative vaccinology

Mucosal Immunology, Two-Volume Set

Volumn , Issue , 2005, Pages 1085-1107

  Hodgins, Douglas C ^a   Yuan, Lijuan ^b   Saif, Linda J ^b   Parreño, Viviana ^c   Corbeil, Lynette B ^d  

^a UNIVERSITY OF GUELPH   (Canada)

^b OHIO STATE UNIVERSITY   (United States)

^c INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^d UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 60549084121     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012491543-5/50065-6     Document Type: Chapter

References (191)

1. Abdullah K.M., Udoh E.A., Shewen P.E., Mellors A. A neutral glycoprotease of Pasteurella haemolytica A1 specifically cleaves O-sialoglycoproteins. Infect. Immun. 1992, 60:56-62.
2. Alonso S., Sola I., Teifke J.P., Reimann I., Izeta A., Balasch M., Plana-Duran J., Moormann R.J., Enjuanes L. In vitro and in vivo expression of foreign genes by transmissible gastroenteritis coronavirus-derived minigenomes. J. Gen. Virol. 2002, 83:567-579.
3. Angen O., Mutters R., Caugant D.A., Olsen J.E., Bisgaard M. Taxonomic relationships of the [Pasteurella] haemolytica complex as evaluated by DNA-DNA hybridizations and 16S rRNA sequencing with proposal of Mannheimia haemolytica gen. nov., comb. nov., M. granulomatis comb. nov., M. glucosida sp. nov., M. ruminalis sp. nov., and M. varigena sp. nov. Int. J. Syst. Bacteriol. 1999, 49:67-86.
4. Appel M.J. Forty years of canine vaccination. Adv. Vet. Med. 1999, 41:309-324.
5. Ardans A.A. Orthomyxoviridae. Veterinary Microbiology 1999, 396-402. Blackwell Science, Malden, Massachusetts. D.C. Hirsh, Y.C. Zee (Eds.).
6. Arthington J.D., Cattell M.B., Quigley J.D., McCoy G.C., Hurley W.L. Passive immunoglobin transfer in newborn calves fed colostrum or spray-dried serum protein alone or as a supplement to colostrum of varying quality. J. Dairy Sci. 2000, 83:2834-2838.
7. Ascon M.A., Hone D.M., Walters N., Pascual D.W. Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity. Infect. Immun. 1998, 66:5470-5476.
8. Babiuk L.A., Acres S.D. Models for bovine respiratory disease. Bovine Respiratory Disease 1984, Texas A&M Press, College Station, Texas. R.W. Loan (Ed.).
9. Babiuk L.A., van Drunen Littel-van den Hurk S., Babiuk S.L. Immunization of animals: from DNA to the dinner plate. Vet. Immunol. Immunopathol. 1999, 72:189-202.
10. Babiuk S., Baca-Estrada M.E., Foldvari M., Storms M., Rabussay D., Widera G., Babiuk L.A. Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 2002, 20:3399-3408.
11. Barrington G.M., McFadden T.B., Huyler M.T., Besser T.E. Regulation of colostrogenesis in cattle. Livest. Prod. Sci. 2000, 70:95-104.
12. Becu T., Polledo G., Gaskin J.M. Immunoprophylaxis of Rhodococcus equi pneumonia in foals. Vet. Microbiol. 1997, 56:193-204.
13. Berg R.L., Firehammer B.D., Border M., Myers L.L. Effects of passively and actively acquired antibody on bovine campylobacteriosis (vibriosis). Am. J. Vet. Res. 1979, 40:21-25.
14. Bertschinger H.U., Fairbrother J.M. Escherichia coli infections. Diseases of Swine 1999, 431-454. Iowa State University Press, Ames, Iowa. 8th ed. B.E. Straw, S. D'Allaire, W.L. Mengeling, D. Taylor (Eds.).
15. Besser T.E., Gay C.C. The importance of colostrum to the health of the neonatal calf. Vet. Clin. North Am. Food Anim. Pract. 1994, 10:107-117.
16. Besser T.E., McGuire T.C., Gay C.C. The transfer of serum IgG1 antibody into the gastrointestinal tract in newborn calves. Vet. Immunol. Immunopathol. 1987, 17:51-56.
17. Besser T.E., Gay C.C., McGuire T.C., Evermann J.F. Passive immunity to bovine rotavirus infection associated with transfer of serum antibody into the intestinal lumen. J. Virol. 1988, 62:2238-2242.
18. Besser T.E., McGuire T.C., Gay C.C., Pritchett L.C. Transfer of functional immunoglobulin G (IgG) antibody into the gastrointestinal tract accounts for IgG clearance in calves. J. Virol. 1988, 62:2234-2237.
19. Boersma W.J., Van Rooij E.M., Scholten J-W., Zwart R.J., Kimman T.G., Bianchi A. Silent memory induction in maternal immune young animals. Vet. Q. 1998, 20:S89-S92.
20. Bohl E.H., Gupta R.K., Olquin M.V., Saif L.J. Antibody responses in serum, colostrum, and milk of swine after infection or vaccination with transmissible gastroenteritis virus. Infect. Immun. 1972, 6:289-301.
21. Bohl E.H., Theil K.W., Saif L.J. Isolation and serotyping of porcine rotaviruses and antigenic comparison with other rotaviruses. J. Clin. Microbiol. 1984, 19:105-111.
22. Bowersock T.L., Shalaby W.S.W., Levy M., Blevins W.E., White M.R., Borie D.L., Park K. The potential use of poly(methacrylic acid) hydrogels for oral administration of drugs and vaccines to ruminants. J. Contr. Rel. 1994, 31:245-254.
23. Bowersock T.L., Shalaby W.S., Levy M., Samuels M.L., Lallone R., White M.R., Borie D.L., Lehmeyer J., Park K. Evaluation of an orally administered vaccine, using hydrogels containing bacterial exotoxins of Pasteurella haemolytica, in cattle. Am. J. Vet. Res. 1994, 55:502-509.
24. Bowersock T.L., HogenEsch H., Suckow M., Guimond P., Martin S., Borie D., Torregrosa S., Park H., Park K. Oral vaccination of animals with antigens encapsulated in alginate microspheres. Vaccine 1999, 17:1804-1811.
25. Braun R.P., Babiuk L.A., Loehr B.I., van Drunen Littel-van den Hurk S. Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1. Virology 1999, 265:46-56.
26. Bresee J.S., Glass R.I., Ivanoff B., Gentsch J.R. Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 1999, 17:2022-2207.
27. Bridger J.C. Small viruses associated with gastroenteritis in animals. Viral Diarrheas of Man and Animals 1990, 161-182. CRC Press, Boca Raton, Florida. L.J. Saif, K.W. Theil (Eds.).
28. Briggs R.E., Tatum F.M. New mucosal vaccine in beef cattle imparts rapid resistance to pneumonic pasteurellosis after mass-medicating on feed. Presented at the U.S. Animal Health Assoc. Mtg. 1999.
29. Brock J.H., Arzabe F.R., Ortega F., Pineiro A. The effect of limited proteolysis by trypsin and chymotrypsin on bovine colostral IgG1. Immunology 1977, 32:215-219.
30. Brockmeier S.I., Lager K.M., Mengeling W.L. Successful pseudorabies vaccination in maternally immune piglets using recombinant vaccinia virus vaccines. Res. Vet. Sci. 1997, 62:281-285.
31. Brogden K.A., DeBey B., Audibert F., Lehmkuhl H., Chedid L. Protection of ruminants by Pasteurella haemolytica A1 capsular polysaccharide vaccines containing muramyl dipeptide analogs. Vaccine 1995, 13:1677-1684.
32. Brugmann M., Drommer W., Reichl U., Boge A. Iscom (immunostimulating complex) vaccine of equine influenza virus: transmission electron microscopic investigation and literature review. Dtsch. Tierarztl. Wochenschr. 1997, 104:196-202.
33. Butler J.E. Bovine immunoglobulins: an augmented review. Vet. Immunol. Immunopathol. 1983, 4:43-152.
34. Carmichael L.E., Joubert J.C., Pollock R.V. A modified live canine parvovirus vaccine. II. Immune response. Cornell Vet. 1983, 73:13-29.
35. Casal J.I., Langeveld J.P., Cortes E., Schaaper W.W., van Dijk E., Vela C., Kamstrup S., Meloen R.H. Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence. J. Virol. 1995, 69:7274-7277.
36. Casal J.I. Use of parvovirus-like particles for vaccination and induction of multiple immune responses. Biotechnol. Appl. Biochem. 1999, 29:141-150.
37. Chambers T.M., Holland R.E., Tudor L.R., Townsend H.G., Cook A., Bogdan J., Lunn D.P., Hussey S., Whitaker-Dowling P., Youngner J.S., Sebring R.W., Penner S.J., Stiegler G.L. A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge. Equine Vet. J. 2001, 33:630-636.
38. Chen H., Schifferli D.M. Enhanced immune responses to viral epitopes by combining macrophage-inducible expression with multimeric display on a Salmonella vector. Vaccine 2001, 19:3009-3018.
39. Ciarlet M., Gilger M.A., Barone C., McArthur M., Estes M.K., Conner M.E. Rotavirus disease, but not infection and development of intestinal histopathological lesions, is age restricted in rabbits. Virology 1998, 251:343-360.
40. Clark B.L., Emery D.L., Dufty J.H. Therapeutic immunization of bulls with the membranes and glycoproteins of Tritrichomonas foetus var. brisbane. Aust. Vet. J. 1984, 61:65-66.
41. Confer A.W., Fulton R.W. Evaluation of Pasteurella and Haemophilus vaccines. The Bovine Proceedings 1995, 27:136-141.
42. Conlon J.A., Shewen P.E., Lo R.Y. Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1. Infect. Immun. 1991, 59:587-591.
43. Conlon J.A., Gallo G.F., Shewen P.E., Adlam C. Comparison of protection of experimentally challenged cattle vaccinated once or twice with a Pasteurella haemolytica bacterial extract vaccine. Can. J. Vet. Res. 1995, 59:179-182.
44. Conner M.E., Ramig A. Viral enteric diseases. Viral Pathogenesis 1997, 713-742. Lippincott-Raven, Philadelphia. N. Nathanson, R. Ahmed (Eds.).
45. Corbeil L.B., Winter A.J. Animal model for the study of genital immune mechanisms: venereal vibrosis of cattle. Immunobiology of Neisseria gonorrhoeae 1978, 293-299. American Society for Microbiology, Washington, DC. G.F. Brooks (Ed.).
46. Corbeil L.B., Schurig G.G., Duncan J.R., Wilkie B.N., Winter A.J. Immunity in the female bovine reproductive tract based on the response to Campylobacter fetus. Adv. Exp. Med. Biol. 1981, 137:729-743.
47. Corbeil L.B., Hodgson J.L., Widders P.R. Immunoglobulin binding by Tritrichomonas foetus. J. Clin. Microbiol. 1991, 29:2710-2714.
48. Corbeil L.B., Munson L., Campero C., BonDurant R.H. Bovine trichomoniasis as a model for development of vaccines against sexually-transmitted disease. Am. J. Reprod. Immunol. 2001, 45:310-319.
49. Coulson B.S., Grimwood K., Hudson I.L., Barnes G.L., Bishop R.F. Role of coproantibody in clinical protection of children during reinfection with rotavirus. J. Clin. Microbiol. 1992, 30:1678-1684.
50. Crawford S.E., Estes M.K., Ciarlet M., Barone C., O'Neal C.M., Cohen J., Conner M.E. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles. J. Virol. 1999, 73:4813-4822.
51. Enjuanes L., Sola I., Almazan F., Ortego J., Izeta A., Gonzalez J.M., Alonso S., Sanchez J.M., Escors D., Calvo E., Riquelme C., Sanchez C. Coronavirus derived expression systems. J. Biotechnol. 2001, 88:183-204.
52. Entriken T. Veterinary Pharmaceuticals and Biologicals 2001, Veterinary Healthcare Communications, Lenexa, KS.
53. Estes M.K., Kang G., Zeng C.Q., Crawford S.E., Ciarlet M. Pathogenesis of rotavirus gastroenteritis. Novartis Found. Symp. 2001, 238:82-96.
54. Farley H. An epizoological study of shipping fever in Kansas. J. Am. Vet. Med. Assoc. 1932, 52:165-172.
55. Fooks A.R. Development of oral vaccines for human use. Curr. Opin. Mol. Ther. 2000, 2:80-86.
56. Franco M.A., Greenberg H.B. Immunity to homologous rotavirus infection in adult mice. Trends Microbiol. 2000, 8:50-52.
57. Frank G.H. Bacteria as etiologic agents in bovine respiratory disease. Bovine Respiratory Disease 1984, Texas A & M Press, College Station, Texas. R.W. Loan (Ed.).
58. Frank G.H., Smith P.C. Prevalence of Pasteurella haemolytica in transported calves. Am. J. Vet. Res. 1983, 44:981-985.
59. Friend S.C., Wilkie B.N., Thomson R.G., Barnum D.A. Bovine pneumonic pasteurellosis: experimental induction in vaccinated and nonvaccinated calves. Can. J. Comp. Med. 1977, 41:77-83.
60. Gatewood D.M., Fenwick B.W., Chengappa M.M. Growth-condition dependent expression of Pasteurella haemolytica A1 outer membrane proteins, capsule, and leukotoxin. Vet. Microbiol. 1994, 41:221-233.
61. Gellin B.G., Katz S.L. Measles: state of the art and future directions. J. Infect. Dis. 1994, 170(Suppl. 1):S3-S14.
62. Glennon A., Jeffs J. NOAH Compendium of Data Sheets for Veterinary Products 2000, National Office of Animal Health, Ltd., Enfield, Middlesex, UK.
63. Glezen W.P. Maternal vaccines. Prim. Care 2001, 28:791-806.
64. Hannant D., Mumford J.A. Cell mediated immune responses in ponies following infection with equine influenza virus (H3N8): the influence of induction culture conditions on the properties of cytotoxic effector cells. Vet. Immunol. Immunopathol. 1989, 21:327-337.
65. Hannant D., Mumford J.A., Jessett D.M. Duration of circulating antibody and immunity following infection with equine influenza virus. Vet. Rec. 1988, 122:125-128.
66. Hannant D., Jessett D.M., O'Neill T., Mumford J.A. Antibody isotype responses in the serum and respiratory tract to primary and secondary infections with equine influenza virus (H3N8). Vet. Microbiol. 1989, 19:293-303.
67. Hannant D., Easeman R., Mumford J. Equine mucosal immune system: intranasal vaccination with inactivated equine influenza virus protects from infection. Proceedings of the 8th International Conference on Equine Infectious Diseases 1998, 50-56. R&W Publications, Newmarket, UK. W. Plowright (Ed.).
68. Harland R.J., McCartney D.H., Potter A.P. Evaluation of P. haemolytica vaccination strategies in beef calves. Proceedings of the 73rd Conference on Research Work in Animal Diseases 1992.
69. Hoar B.R., Jelinski M.D., Ribble C.S., Janzen E.D., Johnson J.C. A comparison of the clinical field efficacy and safety of florfenicol and tilmicosin for the treatment of undifferentiated bovine respiratory disease of cattle in western Canada. Can. Vet. J. 1998, 39:161-166.
70. Hodgins D.C., Shewen P.E. Passive immunity to Pasteurella haemolytica A1 in dairy calves: effects of preparturient vaccination of the dams. Can. J. Vet. Res. 1994, 58:31-35.
71. Hodgins D.C., Shewen P.E. Preparturient vaccination to enhance passive immunity to the capsular polysaccharide of Pasteurella haemolytica A1. Vet. Immunol. Immunopathol. 1996, 50:67-77.
72. Hodgins D.C., Shewen P.E. Serologic responses of young colostrum fed dairy calves to antigens of Pasteurella haemolytica A1. Vaccine 1998, 16:2018-2025.
73. Hodgins D.C., Conlon J.A., Shewen P.E. Respiratory viruses and bacteria in cattle. Polymicrobial Diseases 2002, 213-229. American Society for Microbiology Press, Washington, DC. K.A. Brogden, J.M. Guthmiller (Eds.).
74. Hooper-McGrevy K.E., Giguere S., Wilkie B.N., Prescott J.F. Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia. Am. J. Vet. Res. 2001, 62:1307-1313.
75. Hoshino Y., Saif L.J., Sereno M.M., Chanock R.M., Kapikian A.Z. Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen. J. Virol. 1988, 62:744-748.
76. Hu K.F., Lovgren-Bengtsson K., Morein B. Immunostimulating complexes (ISCOMs) for nasal vaccination. Adv. Drug Deliv. Rev. 2001, 51:149-159.
77. Ikeda J.S., BonDurant R.H., Campero C.M., Corbeil L.B. Conservation of a protective surface antigen of Tritrichomonas foetus. J. Clin. Microbiol. 1993, 31:3289-3295.
78. Ikemori Y., Kuroki M., Peralta R.C., Yokoyama H., Kodama Y. Protection of neonatal calves against fatal enteric coli-bacillosis by administration of egg yolk powder from hens immunized with K99-piliated enterotoxigenic Escherichia coli. Am. J. Vet. Res. 1992, 53:2005-2008.
79. Ikemori Y., Ohta M., Umeda K., Icatlo F.C., Kuroki M., Yokoyama H., Kodama Y. Passive protection of neonatal calves against bovine coronavirus-induced diarrhea by administration of egg yolk or colostrum antibody powder. Vet. Microbiol. 1997, 58:105-111.
80. Iosef C., Van Nguyen T., Jeong K., Bengtsson K., Morein B., Kim Y., Chang K.O., Azevedo M.S., Yuan L., Nielsen P., Saif L.J. Systemic and intestinal antibody secreting cell responses and protection in gnotobiotic pigs immunized orally with attenuated Wa human rotavirus and Wa 2/6-rotavirus-like particles associated with immunostimulating complexes. Vaccine 2002, 20:1741-1753.
81. Jiang W., Baker H.J., Swango L.J., Schorr J., Self M.J., Smith B.F. Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus. Vaccine 1998, 16:601-607.
82. Jones G.E., Donachie W., Sutherland A.D., Knox D.P., Gilmour J.S. Protection of lambs against experimental pneumonic pasteurellosis by transfer of immune serum. Vet. Microbiol. 1989, 20:59-71.
83. Jones S.L., Blikslager A.T. Role of the enteric nervous system in the pathophysiology of secretory diarrhea. J. Vet. Intern. Med. 2002, 16:222-228.
84. Kacskovics I., Wu Z., Simister N.E., Frenyo L.V., Hammarstrom L. Cloning and characterization of the bovine MHC class I-like Fc receptor. J. Immunol. 2000, 164:1889-1897.
85. Kaehler K.L., Markham R.J., Muscoplat C.C., Johnson D.W. Evidence of species specificity in the cytocidal effects of Pasteurella haemolytica. Infect. Immun. 1980, 30:615-616.
86. Kania S.A., Reed S.L., Thomford J.W., BonDurant R.H., Hirata K., Corbeil R.R., North M.J., Corbeil L.B. Degradation of bovine complement C3 by trichomonad extracellular proteinase. Vet. Immunol. Immunopathol. 2001, 78:83-96.
87. Kapikian A.Z., Hoshino Y., Chanock R.M. Rotaviruses. Fields Virology 2001, 1787-1834. Lippincott-Raven, Philadelphia. 4th ed. D.M. Kinipe, P.M. Howley (Eds.).
88. Kelly A.P., Janzen E.D. A review of morbidity and mortality rates and disease occurrence in North American feedlot cattle. Can. Vet. J. 1986, 27:496-500.
89. Kim Y., Nielsen P.R., Hodgins D., Chang K.O., Saif L.J. Lactogenic antibody responses in cows vaccinated with recombinant bovine rotavirus-like particles (VLPs) of two serotypes or inactivated bovine rotavirus vaccines. Vaccine 2002, 20:1248-1258.
90. Kohara J., Tsunemitsu H. Correlation between maternal serum antibodies and protection against bovine rotavirus diarrhea in calves. J. Vet. Med. Sci. 2000, 62:219-221.
91. Kuroki M., Ohta M., Ikemori Y., Peralta R.C., Yokoyama H., Kodama Y. Passive protection against bovine rotavirus in calves by specific immunoglobulins from chicken egg yolk. Arch. Virol. 1994, 138:143-148.
92. Kvasnicka W.G., Hanks D., Huang J.-C., Hall M.R., Sandblom D., Chu H.J., Chavez L., Acree W.M. Clinical evaluation of the efficacy of inoculating cattle with a vaccine containing Tritrichomonas foetus. Am. J. Vet. Res. 1992, 53:2023-2027.
93. Langeveld J.P., Brennan F.R., Martinez-Torrecuadrada J.L., Jones T.D., Boshuizen R.S., Vela C., Casal J.I., Kamstrup S., Dalsgaard K., Meloen R.H., Bendig M.M., Hamilton W.D. Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus. Vaccine 2001, 19:3661-3670.
94. Larson L.J., Schultz R.D. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection. Am. J. Vet. Res. 1997, 58:360-363.
95. Lee C.W., Shewen P.E., Cladman W.M., Conlon J.A., Mellors A., Lo R.Y. Sialoglycoprotease of Pasteurella haemolytica A1: detection of antisialoglycoprotease antibodies in sera of calves. Can. J. Vet. Res. 1994, 58:93-98.
96. Lee R.W., Strommer J., Hodgins D., Shewen P.E., Niu Y., Lo R.Y. Towards development of an edible vaccine against bovine pneumonic pasteurellosis using transgenic white clover expressing a Mannheimia haemolytica A1 leukotoxin 50 fusion protein. Infect. Immun. 2001, 69:5786-5793.
97. Lundgren O., Peregrin A.T., Persson K., Kordasti S., Uhnoo I., Svensson L. Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea. Science 2000, 287:491-495.
98. Lunn D.P., Soboll G., Schram B.R., Quass J., McGregor M.W., Drape R.J., Macklin M.D., McCabe D.E., Swain W.F., Olsen C.W. Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene. Vaccine 1999, 17:2245-2258.
99. Marquardt R.R. Control of intestinal diseases in pigs by feeding specific chicken egg antibodies. Egg Nutrition and Biotechnology 2000, 289-299. CABI Publishing, Wallingford, Oxon, UK. J.S. Sim, S. Nakai, W. Guenter (Eds.).
100. McNeal M.M., VanCott J.L., Choi A.H., Basu M., Flint J.A., Stone S.C., Clements J.D., Ward R.L. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT (R192G). J. Virol. 2002, 76:560-568.
101. Mebus C.A., White R.G., Stair E.L., Rhodes M.B., Twiehaus M.J. Neonatal calf diarrhea: results of a field trial using a reo-like virus vaccine. Vet. Med. Small Anim. Clin. 1972, 67:173-174.
102. Mechor G.D., Jim G.K., Janzen E.D. Comparison of penicillin, oxytetracycline, and trimethoprim-sulfadoxine in the treatment of acute undifferentiated bovine respiratory disease. Can. Vet. J. 1988, 29:438-443.
103. Miller A.W., Howard L.H., Bayard E.S., Smith R.W., Stanard S.J., Jones J.D., Hilton G., Killham B.J., Truam J. Report of committee on miscellaneous transmissible diseases. J. Am. Vet. Med. Assoc. 1927, 70:952-955.
104. Mine Y., Kovacs-Nolan J. Chicken egg yolk antibodies as therapeutics in enteric infectious disease: a review. J. Med. Food 2002, 5:159-169.
105. Moon H.W., Bunn T.O. Vaccines for preventing enterotoxigenic Escherichia coli infections in farm animals. Vaccine 1993, 11:200-213.
106. Morck D.W., Raybould T.J., Acres S.D., Babiuk L.A., Nelligan J., Costerton J.W. Electron microscopic description of glycocalyx and fimbriae on the surface of Pasteurella haemolytica-A1. Can. J. Vet. Res. 1987, 51:83-88.
107. Morck D.W., Olson M.E., Acres S.D., Daoust P.Y., Costerton J.W. Presence of bacterial glycocalyx and fimbriae on Pasteurella haemolytica in feedlot cattle with pneumonic pasteurellosis. Can. J. Vet. Res. 1989, 53:167-171.
108. Morck D.W., Ellis B.D., Domingue P.A., Olson M.E., Costerton J.W. In vivo expression of iron regulated outer-membrane proteins in Pasteurella haemolytica-A1. Microb. Pathog. 1991, 11:373-378.
109. Morein B., Villacres-Eriksson M., Ekstrom J., Hu K., Behboudi S., Lovgren-Bengtsson K. ISCOM: a delivery system for neonates and for mucosal administration. Adv. Vet. Med. 1999, 41:405-413.
110. Morley P.S., Townsend H.G., Bogdan J.R., Haines D.M. Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses. J. Am. Vet. Med. Assoc. 1999, 215:61-66.
111. Mosier D.A. Bacterial pneumonia. Vet. Clin. North Am. Food Anim. Pract. 1997, 13:483-493.
112. Mosier D.A., Confer A.W., Panciera R.J. The evolution of vaccines for bovine pneumonic pasteurellosis. Res. Vet. Sci. 1989, 47:1-10.
113. Mosier D.A., Simons K.R., Vestweber J.G. Passive protection of calves with Pasteurella haemolytica antiserum. Am. J. Vet. Res. 1995, 56:1317-1321.
114. Mosier D.A., Panciera R.J., Rogers D.P., Uhlich G.A., Butine M.D., Confer A.W., Basaraba R.J. Comparison of serologic and protective responses induced by two Pasteurella vaccines. Can. J. Vet. Res. 1998, 62:178-182.
115. Moxley R.A., Olson L.D. Clinical evaluation of transmissible gastroenteritis virus vaccines and vaccination procedures for inducing lactogenic immunity in sows. Am. J. Vet. Res. 1989, 50:111-118.
116. Mumford J., Wood J. WHO/OIE meeting: consultation on newly emerging strains of equine influenza. Vaccine 1993, 11:1172-1175.
117. Mumford J.A., Jessett D., Dunleavy U., Wood J., Hannant D., Sundquist B., Cook R.F. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines. Vaccine 1994, 12:857-863.
118. Mumford J.A., Jessett D.M., Rollinson E.A., Hannant D., Draper M.E. Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines. Vet. Rec. 1994, 134:158-162.
119. Mumford J.A., Wilson H., Hannant D., Jessett D.M. Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. Epidemiol. Infect. 1994, 112:421-437.
120. Nelson K.M., Schram B.R., McGregor M.W., Sheoran A.S., Olsen C.W., Lunn D.P. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine 1998, 16:1306-1313.
121. Newmark P. Bark extract amplifies vaccine. Biotechnology 1988, 6:23.
122. O'Neal C.M., Clements J.D., Estes M.K., Conner M.E. Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge. J. Virol. 1998, 72:3390-3393.
123. Park S., Sestak K., Hodgins D.C., Shoup D.I., Ward L.A., Jackwood D.J., Saif L.J. Immune response of sows vaccinated with attenuated transmissible gastroenteritis virus (TGEV) and recombinant TGEV spike protein vaccines and protection of their suckling pigs against virulent TGEV challenge exposure. Am. J. Vet. Res. 1998, 59:1002-1008.
124. Parreño V., Hodgins D.C., de Arriba L., Kang S.Y., Yuan L., Ward L.A., To T.L., Saif L.J. Serum and intestinal isotype antibody responses to Wa human rotavirus in gnotobiotic pigs are modulated by maternal antibodies. J. Gen. Virol. 1999, 80:1417-1428.
125. Parsonson I.M., Clark B.L., Dufty J.H. Early pathogenesis and pathology of Tritrichomonas foetus infection in virgin heifers. J. Comp. Pathol. 1976, 86:59-66.
126. Pastoret P.P. Immunology of cattle. Handbook of Vertebrate Immunology 1998, Academic Press, San Diego. P.P. Pastoret (Ed.).
127. Pogonka T., Klotz C., Kovacs F., Lucius R. A single dose of recombinant Salmonella typhimurium induces specific humoral immune responses against heterologous Eimeria tenella antigens in chicken. Int. J. Parasitol. 2003, 33:81-88.
128. Pollock R.V., Carmichael L.E. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination. J. Am. Vet. Med. Assoc. 1982, 180:37-42.
129. Potter A.A., Schryvers A.B., Ogunnariwo J.A., Hutchins W.A., Lo R.Y., Watts T. Protective capacity of the Pasteurella haemolytica transferrin-binding proteins TbpA and TbpB in cattle. Microb. Pathog. 1999, 27:197-206.
130. Pratelli A., Cavalli A., Normanno G., De Palma M.G., Pastorelli G., Martella V., Buonavoglia C. Immunization of pups with maternally derived antibodies to canine parvovirus (CPV) using a modified-live variant (CPV-2b). J. Vet. Med. B Infect. Dis. Vet. Public Health 2000, 47:273-276.
131. Purdy C.W., Livingston C.W., Frank G.H., Cummins J.M., Cole N.A., Loan R.W. A live Pasteurella haemolytica vaccine efficacy trial. J. Am. Vet. Med. Assoc. 1986, 188:589-591.
132. Quigley J.D., Drewry J.J. Nutrient and immunity transfer from cow to calf pre- and postcalving. J. Dairy Sci. 1998, 81:2779-2790.
133. Rankin R., Pontarollo R., Ioannou X., Krieg A.M., Hecker R., Babiuk L.A., van Drunen Littel-van den Hurk S. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev. 2001, 11:333-340.
134. Rebelatto M.C., Guimond P., Bowersock T.L., HogenEsch H. Induction of systemic and mucosal immune response in cattle by intranasal administration of pig serum albumin in alginate microparticles. Vet. Immunol. Immunopathol. 2001, 83:93-105.
135. Rehmtulla A.J., Thomson R.G. A review of the lesions in shipping fever of cattle. Can. Vet. J. 1981, 22:1-8.
136. Rhyan J.C., Wilson K.L., Wagner B., Anderson M.L., BonDurant R.H., Burgess D.E., Mutwiri G.K., Corbeil L.B. Demonstration of Tritrichomonas foetus in the external genitalia and of specific antibodies in preputial secretions of naturally infected bulls. Vet. Pathol. 1999, 36:406-411.
137. Roux M.E., McWilliams M., Phillips-Quagliata J.M., Weisz-Carrington P., Lamm M.E. Origin of IgA-secreting plasma cells in the mammary gland. J. Exp. Med. 1977, 146:1311-1322.
138. Saif L., Yuan L., Ward L., To T. Comparative studies of the pathogenesis, antibody immune responses, and homologous protection to porcine and human rotaviruses in gnotobiotic piglets. Adv. Exp. Med. Biol. 1997, 412:397-403.
139. Saif L.J. Comparative pathogenesis of enteric viral infections of swine. Mechanisms in the Pathogenesis of Enteric Diseases 1999, 2:47-59. Kluwer Academic/Plenum Publishers, New York. P. Paul, D. Francis (Eds.).
140. Saif L.J. Enteric viral infections of pigs and strategies for induction of mucosal immunity. Adv. Vet. Med. 1999, 41:429-446.
141. Saif L.J., Bohl E.H. Passive immunity to transmissible gastroenteritis virus: intramammary viral inoculation of sows. Ann. N.Y. Acad. Sci. 1983, 409:708-723.
142. Saif L.J., Fernandez F.M. Group A rotavirus veterinary vaccines. J. Infect. Dis. 1996, 174(Suppl 1):S98-S106.
143. Saif L.J., Jackwood D.J. Enteric virus vaccines: theoretical considerations, current status, and future approaches. Viral Diarrheas of Man and Animals 1990, 313-329. CRC Press, Boca Raton, Florida. L.J. Saif, K.W. Theil (Eds.).
144. Saif L.J., Wesley R.D. Transmissible gastroenteritis and porcine respiratory coronavirus. Diseases of Swine 1999, 295-325. Iowa State University Press, Ames, Iowa. 8th ed. B.E. Straw, S. D'Allaire, W.L. Mengeling, D. Taylor (Eds.).
145. Saif L.J., Bohl E.H., Gupta R.K. Isolation of porcine immunoglobulins and determination of the immunoglobulin classes of transmissible gastroenteritis viral antibodies. Infect. Immun. 1972, 6:600-609.
146. Saif L.J., Redman D.R., Smith K.L., Theil K.W. Passive immunity to bovine rotavirus in newborn claves fed colostrum supplements from immunized or nonimmunized cows. Infect. Immun. 1983, 41:1118-1131.
147. Saif L.J., Ward L.A., Yuan L., Rosen B.I., To T.L. The gnotobiotic piglet as a model for studies of disease pathogenesis and immunity to human rotaviruses. Arch. Virol. Suppl. 1996, 12:153-161.
148. Salmon H. Lactogenic immunity and vaccinal protection in swine. Vet. Res. 1995, 26:232-237.
149. Salmon H. Mammary gland immunology and neonate protection in pigs. Biology of the Mammary Gland 2000, 279-287. Kluwer Academic/Plenum, New York. J.A. Mol, R.A. Clegg (Eds.).
150. Schaller J.P., Saif L.J., Cordle C.T., Candler E., Winship T.R., Smith K.L. Prevention of human rotavirus-induced diarrhea in gnotobiotic piglets using bovine antibody. J. Infect. Dis. 1992, 165:623-630.
151. Sheldrake R.F., Husband A.J., Watson D.L. Specific antibody-containing cells in the mammary gland of non-lactating sheep after intraperitoneal and intramammary immunization. Res. Vet. Sci. 1985, 38:312-316.
152. Shewen P.E., Wilkie B.N. Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes. Infect. Immun. 1982, 35:91-94.
153. Shewen P.E., Wilkie B.N. Evidence for the Pasteurella haemolytica cytotoxin as a product of actively growing bacteria. Am. J. Vet. Res. 1985, 46:1212-1214.
154. Shoo M.K. Experimental bovine pneumonic pasteurellosis: a review. Vet. Rec. 1989, 124:141-144.
155. Siadat-Pajouh M., Cai L. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant. Viral Immunol. 2001, 14:31-47.
156. Siegrist C.-A., Barrios C., Martinez X., Brandt C., Berney M., Córdova M., Kovarik J., Lambert P.-H. Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur. J. Immunol. 1998, 28:4138-4148.
157. Smith C.K., Davidson J.N., Henry C.W. Evaluating a live vaccine for Pasteurella haemolytica in dairy calves. Vet. Med. 1985, 80:78-88.
158. Straus D.C., Purdy C.W. In vivo production of neuraminidase by Pasteurella haemolytica A1 in goats after transthoracic challenge. Infect. Immun. 1994, 62:4675-4678.
159. Svennerholm A.M., Holmgren J., Hanson L.A., Lindblad B.S., Quereshi F., Rahimtoola R.J. Boosting of secretory IgA antibody responses in man by parenteral cholera vaccination. Scand. J. Immunol. 1977, 6:1345-1349.
160. Talbot J.A., Nielsen K., Corbeil L.B. Cleavage of proteins of reproductive secretions by extracellular proteinases of Tritrichomonas foetus. Can. J. Microbiol. 1991, 37:384-390.
161. Taylor J., Tartaglia J., Moran T., Webster R., Bouquet J.-F., Quimby F., Holmes D., Laplace E., Mickle T., Paoletti E. The role of poxvirus vectors in influenza vaccine development. Proceedings of the 3rd International Symposium on Avian Influenza 1992, 311-335. University of Wisconsin, Madison, Wisconsin.
162. Thorlakson B., Martin W., Peters D. A field trial to evaluate the efficacy of a commercial Pasteurella haemolytica bacterial extract in preventing bovine respiratory disease. Can. Vet. J. 1990, 31:573-579.
163. Timoney P.J. Equine influenza. Comp. Immunol. Microbiol. Infect. Dis. 1996, 19:205-211.
164. Tizard I.R. Veterinary Immunology: An Introduction 2000, 210-252. WB Saunders, Philadelphia. 6th ed.
165. Townsend H.G., Penner S.J., Watts T.C., Cook A., Bogdan J., Haines D.M., Griffin S., Chambers T., Holland R.E., Whitaker-Dowling P., Youngner J.S., Sebring R.W. Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials. Equine Vet. J. 2001, 33:637-643.
166. Tuboly T., Yu W., Bailey A., Degrandis S., Du S., Erickson L., Nagy E. Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants. Vaccine 2000, 18:2023-2028.
167. Tyler-McGowan C.M., Hodgson J.L., Hodgson D.R. Failure of passive transfer in foals: incidence and outcome on four studs in New South Wales. Aust. Vet. J. 1997, 75:56-59.
168. Van Binnendijk R.S., Poelen M.C., van Amerongen G., de Vries P., Osterhaus A.D. Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J. Infect. Dis. 1997, 175:524-532.
169. VanCott J.L., Brim T.A., Simkins R.A., Saif L.J. Isotype-specific antibody-secreting cells to transmissible gastroenteritis virus and porcine respiratory coronavirus in gut- and bronchus-associated lymphoid tissues of suckling pigs. J. Immunol. 1993, 150:3990-4000.
170. VanCott J.L., Brim T.A., Lunney J.K., Saif L.J. Contribution of antibody-secreting cells induced in mucosal lymphoid tissues of pigs inoculated with respiratory or enteric strains of coronavirus to immunity against enteric coronavirus challenge. J. Immunol. 1994, 152:3980-3990.
171. Van der Stede Y., Cox E., Verdonck F., Vancaeneghem S., Goddeeris B.M. Reduced faecal excretion of F4(+)-E. coli by the intramuscular immunisation of suckling piglets by the addition of 1alpha, 25-dihydroxyvitamin D(3) or CpG-oligodeoxynucleotides. Vaccine 2003, 21:1023-1032.
172. Van Donkersgoed J., Guenther C., Evans B.N., Potter A.A., Harland R.J. Effects of various vaccination protocols on passive and active immunity to Pasteurella haemolytica and Haemophilus somnus in beef calves. Can. Vet. J. 1995, 36:424-429.
173. Van Maanen C., Cullinane A. Equine influenza virus infections: an update. Vet. Q. 2002, 24:79-94.
174. Van Oirschot J.T., Bruin G., de Boer-Luytze E., Smolders G. Maternal antibodies against equine influenza virus in foals and their interference with vaccination. Zentralbl. Veterinarmed [B] 1991, 38:391-396.
175. Wagstrom E.A., Yoon K.J., Zimmerman J.J. Immune components in porcine mammary secretions. Viral Immunol. 2000, 13:383-397.
176. Waltner-Toews D., Martin S.W., Meek A.H., McMillan I., Crouch C.F. A field trial to evaluate the efficacy of a combined rotavirus-coronavirus/Escherichia coli vaccine in dairy cattle. Can. J. Comp. Med. 1985, 49:1-9.
177. Ward L.A., Rich E.D., Besser T.E. Role of maternally derived circulating antibodies in protection of neonatal swine against porcine group A rotavirus. J. Infect. Dis. 1996, 174:276-282.
178. Ward L.A., Yuan L., Rosen B.I., To T.L., Saif L.J. Development of mucosal and systemic lymphoproliferative responses and protective immunity to human group A rotaviruses in a gnotobiotic pig model. Clin. Diagn. Lab. Immunol. 1996, 3:342-350.
179. Ward R.L., McNeal M.M., Sheridan J.F. Development of an adult mouse model for studies on protection against rotavirus. J. Virol. 1990, 64:5070-5075.
180. Weisz-Carrington P., Roux M.E., McWilliams M., Phillips-Quagliata J.M., Lamm M.E. Hormonal induction of the secretory immune system in the mammary gland. Proc. Natl. Acad. Sci. USA 1978, 75:2928-2932.
181. Westrom B.R., Karlsson B.W., Svendsen J. Levels of serum protease inhibitors during fetal and postnatal development of the pig. Biol. Neonate 1982, 41:22-31.
182. Whiteley L.O., Maheswaran S.K., Weiss D.J., Ames T.R., Kannan M.S. Pasteurella haemolytica A1 and bovine respiratory disease: pathogenesis. J. Vet. Intern. Med. 1992, 6:11-22.
183. Wilson W.D. Equine influenza. Vet. Clin. North Am. Equine Pract. 1993, 9:257-282.
184. Wira C.R., Rossoll R.M. Antigen-presenting cells in the female reproductive tract: influence of estrous cycle on antigen presentation by uterine epithelial and stromal cells. Endocrinology 1995, 136:4526-4534.
185. Yates P., Mumford J.A. Equine influenza vaccine efficacy: the significance of antigenic variation. Vet. Microbiol. 2000, 74:173-177.
186. Yates W.D. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can. J. Comp. Med. 1982, 46:225-263.
187. Yokohama H., Hashi T., Umeda K., Icatlo F.C., Kuroki M., Ikemori Y., Kodama Y. Effect of oral egg antibody in experimental F18+ Escherichia coli infection in weaned pigs. J. Vet. Med. Sci. 1997, 59:917-921.
188. Yu J., Langridge W.H. A plant-based multicomponent vaccine protects mice from enteric diseases. Nat. Biotechnol. 2001, 19:548-552.
189. Yuan L., Saif L.J. Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model. Vet. Immunol. Immunopathol. 2002, 87:147-160.
190. Yuan L., Ward L.A., Rosen B.I., To T.L., Saif L.J. Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J. Virol. 1996, 70:3075-3083.
191. Yuan L., Geyer A., Saif L.J. Short-term immunoglobulin A B-cell memory resides in intestinal lymphoid tissues but not in bone marrow of gnotobiotic pigs inoculated with Wa human rotavirus. Immunology 2001, 103:188-198.